Finance

Beta
Lists
LXS:ETR
Lanxess AG
€15.71
+2.81%
(+0.43) 1D
Jun 11, 5:35:06 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for LXS...
Open
€15.31
High
€15.74
Low
€15.18
Mkt. cap
1.32B
Avg. vol.
617.28K
Volume
324.46K
Dividend
0.64%
Quarterly dividend
€0.03
Ex-dividend date
May 22, 2026
52-wk high
€27.68
52-wk low
€11.03
EPS
-€7.65
Shares outstanding
86.35M
No. of employees
12K
Open
€15.31
High
€15.74
Low
€15.18
Mkt. cap
1.32B
Avg. vol.
617.28K
Volume
324.46K
Dividend
0.64%
Quarterly dividend
€0.03
Ex-dividend date
May 22, 2026
52-wk high
€27.68
52-wk low
€11.03
EPS
-€7.65
Shares outstanding
86.35M
No. of employees
12K
Analyst outlook
Analyst Ratings
Based on 12 analysts giving stock ratings to LXS in the past 3 months
Hold
Buy
1
Hold
7
Sell
4
12 month forecast
Based on 12 Wall Street analysts offering 12 month price targets for LXS in the last 3 months.
Highest
Current €15.71
€21.11 (+34.36%)
Average
€16.77 (+6.72%)
Lowest
€11.06 (-29.62%)
News stories
From sources across the web
Profile
Lanxess AG is a German specialty chemicals company based in Cologne, Germany. It was founded in 2004 after Bayer AG spun off its chemicals division and parts of its polymers business. Wikipedia
About Lanxess AG
CEOMatthias Zachert
Employees11.6K
FoundedJul 1, 2004
HeadquartersCologne, North Rhine-Westphalia, Germany
SectorChemical industry
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
-€0.50 / -€0.42
-19.05%miss
Revenue / Est. (EUR)
1.38B / 1.39B
-0.64%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.47B
1.34B
1.27B
1.38B
Cost of goods sold
1.14B
1.08B
1.04B
1.12B
Cost of revenue
1.14B
1.08B
1.04B
1.12B
Research and development expenses
24.00M
22.00M
21.00M
26.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
281.00M
243.00M
277.00M
264.00M
Operating expense
356.00M
282.00M
282.00M
302.00M
Total operating expenses
1.50B
1.37B
1.32B
1.42B
Operating income
-29.00M
-28.00M
-54.00M
-40.00M
Other non operating income
11.00M
-
44.00M
-23.00M
EBT including unusual items
-55.00M
-68.00M
-287.00M
-136.00M
EBT excluding unusual items
-55.00M
-68.00M
-80.00M
-136.00M
Income tax expense
-10.00M
8.00M
111.00M
5.00M
Effective tax rate
18.18%
-11.76%
-38.68%
-3.68%
Other operating expenses
51.00M
17.00M
-16.00M
12.00M
Net income
-45.00M
-77.00M
-398.00M
-141.00M
Net profit margin
-3.07%
-5.75%
-31.39%
-10.23%
Earnings per share
0.59
-0.07
0.37
-0.50
Interest and investment income
1.00M
1.00M
1.00M
2.00M
Interest expense
-10.00M
-9.00M
-13.00M
-11.00M
Net interest expenses
-9.00M
-8.00M
-12.00M
-9.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
102.00M
105.00M
62.50M
81.00M
Gain or loss from assets sale
-76.00M
-
-4.00M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more